Publications by authors named "Yurika Tachibana"

P-glycoprotein (P-gp), a multidrug efflux pump encoded by the (formerly ) gene, plays a crucial role in limiting drug absorption and eliminating toxic compounds in both humans and dogs. However, species-specific differences in P-gp substrates necessitate the development of canine-specific evaluation systems. Canine intestinal organoids derived monolayers offer a promising platform for studying drug transport, yet P-gp-mediated transport in these models remains unexplored.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICIs), specifically c4G12, show promise in treating various advanced malignant tumors in dogs, including osteosarcoma and nasal adenocarcinoma, based on a clinical study conducted at Hokkaido University.
  • The study involved 12 dogs, with a treatment regimen of c4G12 administered bi-weekly, revealing a significant incidence of treatment-related adverse effects in 8 dogs, though most were manageable.
  • The results indicate a 25% objective response rate among dogs with measurable disease, highlighting the need for further research to better understand which tumor types respond best to this treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICIs), like the anti-PD-L1 antibody, have shown limited effectiveness in treating canine malignant melanoma.
  • Recent research on humans indicates that combining radiation therapy (RT) with ICIs can enhance systemic antitumor immunity.
  • This study found that hypofractionated RT followed by anti-PD-L1 therapy showed improved clinical benefits and overall survival in dogs, particularly for those who had previous RT, suggesting this combination might be a promising treatment strategy with manageable side effects.
View Article and Find Full Text PDF

Animal organoid models derived from farm and companion animals have great potential to contribute to human health as a One Health initiative, which recognize a close inter-relationship among humans, animals and their shared environment and adopt multi-and trans-disciplinary approaches to optimize health outcomes. With recent advances in organoid technology, studies on farm and companion animal organoids have gained more attention in various fields including veterinary medicine, translational medicine and biomedical research. Not only is this because three-dimensional organoids possess unique characteristics from traditional two-dimensional cell cultures including their self-organizing and self-renewing properties and high structural and functional similarities to the originating tissue, but also because relative to conventional genetically modified or artificially induced murine models, companion animal organoids can provide an excellent model for spontaneously occurring diseases which resemble human diseases.

View Article and Find Full Text PDF

Extensive studies have been conducted to characterize the unique phenomena of equine pregnancy. Most studies have focused on embryo transmigration when the embryo is covered with a mucin-like glycoprotein capsule and on the characterization of the chorionic girdle and chorionic gonadotropin (CG) secretion. However, the events preceding and following capsule disappearance have not been well studied.

View Article and Find Full Text PDF

Despite enormous efforts, biochemical and molecular mechanisms associated with equine reproduction, particularly processes of pregnancy establishment, have not been well characterized. Previously, PCR-selected suppression subtraction hybridization analysis was executed to identify unique molecules functioning in the equine endometrium during periods of pregnancy establishment, and granzyme B (GZMB) cDNA was found in the pregnant endometrial cDNA library. Because GZMB is produced from natural killer (NK) cells, endometrial expression of GZMB and immune-related transcripts were characterized in this study.

View Article and Find Full Text PDF